Literature DB >> 9834734

Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.

J M Wieder1, R L Moy.   

Abstract

BACKGROUND: Cosmetic denervation of hyperfunctional facial lines using botulinum toxin (Botox, Allergan, Inc., Irvine, CA) has gained growing popularity over recent years. Understanding the clinical use and effects of botulinum toxin requires a thorough understanding of the muscular anatomy of the treatment areas.
OBJECTIVE: The purpose of this article is to review the anatomy of the frown, forehead, and periocular regions. Function of individual muscles is discussed to understand proper injection technique.
CONCLUSIONS: The anatomy of the frown, forehead, and periocular regions is complex. Individual muscles are tightly intertwined and treatment of one anatomic region may affect many different muscles. A complete understanding of the anatomy of the upper face is essential to ensure proper injection technique, safe and predictable results as well as anticipating complications.

Mesh:

Substances:

Year:  1998        PMID: 9834734

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  4 in total

1.  [Treatment of wrinkles with botulinum toxin].

Authors:  I Lanzl; R-L Merté
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

2.  Dynamic evaluation of facial muscles: 3D skin displacement vector analysis using a facial painting model.

Authors:  Hyoung-Jin Moon; Won Lee; Ji Yun Choi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-07-22

Review 3.  Application of botulinum toxin in maxillofacial field: Part II. Wrinkle, intraoral ulcer, and cranio-maxillofacial pain.

Authors:  Kyung-Hwan Kwon; Kyung Su Shin; Sung Hee Yeon; Dae Gun Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-10-16

Review 4.  Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines.

Authors:  Kyu-Ho Yi; Ji-Hyun Lee; Hye-Won Hu; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2022-04-10       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.